scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1018017426 |
P356 | DOI | 10.1186/1741-7015-11-45 |
P932 | PMC publication ID | 3621796 |
P698 | PubMed publication ID | 23438147 |
P5875 | ResearchGate publication ID | 235727861 |
P50 | author | Ramon Sagarra Álamo | Q59204213 |
Joan J Cabré | Q59204242 | ||
Jordi Salas-Salvadó | Q35028955 | ||
Bernardo Costa | Q57298267 | ||
P2093 | author name string | Josep L Piñol | |
Oriol Solà-Morales | |||
Xavier Mundet | |||
Francisco Barrio | |||
Ramon Sagarra | |||
DE-PLAN-CAT/PREDICE Research Group | |||
P2860 | cites work | International Diabetes Federation: a consensus on Type 2 diabetes prevention | Q80241108 |
Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting | Q21245257 | ||
Genetic prediction of future type 2 diabetes | Q21563435 | ||
Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults | Q22250879 | ||
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 | ||
Diagnosis and Classification of Diabetes Mellitus | Q22255454 | ||
International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes | Q24642456 | ||
Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance | Q28186874 | ||
Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis | Q30829257 | ||
A1C level and future risk of diabetes: a systematic review | Q33932887 | ||
Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention delivery | Q34371263 | ||
Risk assessment tools for identifying individuals at risk of developing type 2 diabetes | Q35095114 | ||
Risk models and scores for type 2 diabetes: systematic review | Q35575823 | ||
A risk score to predict type 2 diabetes mellitus in an elderly Spanish Mediterranean population at high cardiovascular risk | Q35839851 | ||
Metabolic syndrome and its components as predictors of incident type 2 diabetes mellitus in an Aboriginal community | Q37122916 | ||
Estimating the potential population impact of stepwise screening strategies for identifying and treating individuals at high risk of Type 2 diabetes: a modelling study | Q37271291 | ||
Tools for predicting the risk of type 2 diabetes in daily practice | Q37330190 | ||
Take action to prevent diabetes--the IMAGE toolkit for the prevention of type 2 diabetes in Europe | Q39928512 | ||
A European evidence-based guideline for the prevention of type 2 diabetes. | Q43100057 | ||
A1C: recommendations, debates, and questions. | Q43235338 | ||
Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention | Q44233266 | ||
The diabetes risk score: a practical tool to predict type 2 diabetes risk | Q44333486 | ||
Socioeconomic position and effectiveness of lifestyle intervention in prevention of type 2 diabetes: one-year follow-up of the FIN-D2D project | Q44558382 | ||
Shifting from glucose diagnostic criteria to the new HbA(1c) criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population. | Q51376301 | ||
Validation of the Finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece. | Q51384908 | ||
The European Perspective of Type 2 Diabetes Prevention: Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) Project | Q58417532 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | Finland | Q33 |
P304 | page(s) | 45 | |
P577 | publication date | 2013-02-21 | |
P1433 | published in | BMC Medicine | Q4835947 |
P1476 | title | Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy | |
P478 | volume | 11 |
Q34671155 | Diabetes mellitus: The epidemic of the century |
Q36306607 | Different type 2 diabetes risk assessments predict dissimilar numbers at 'high risk': a retrospective analysis of diabetes risk-assessment tools |
Q35088520 | Evaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population |
Q34159256 | Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome. |
Q51458635 | Examining the relationship between HbA1c and diabetes risk models in a European population indicates a lower threshold to identify 'high risk' is required. |
Q37693898 | Patterns of diabetes care in Slovenia, Croatia, Serbia, Bulgaria and Romania : An observational, non-interventional, cross-sectional study. |
Q37115361 | Performance of the Finnish Diabetes Risk Score and a Simplified Finnish Diabetes Risk Score in a Community-Based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: The SPREDIA-2 Study |
Q34798255 | Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population |
Q36842120 | Rationale and design of the DP-TRANSFERS project: diabetes prevention-transferring findings from European research to society in Catalonia |
Q54702903 | Uptake of screening for type 2 diabetes risk in general dental practice; an exploratory study. |
Q35906741 | Validating prediction scales of type 2 diabetes mellitus in Spain: the SPREDIA-2 population-based prospective cohort study protocol |
Q58778969 | Validation of DIABSCORE in screening for Type 2 Diabetes and prediabetes in Tunisian population |
Q37322783 | Validity of the Finnish Diabetes Risk Score for Detecting Undiagnosed Type 2 Diabetes among General Medical Outpatients in Botswana |
Q51307056 | [Consensus on the detection and management of prediabetes. Consensus and Clinical Guidelines Working Group of the Spanish Diabetes Society]. |
Q88983094 | Recomendaciones preventivas cardiovasculares. Actualización PAPPS 2018 |
Search more.